RYAN THOMAS F JR

CIK 00012633661 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001263366

Recent Transactions

50 trades

Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2022-03-01$38.76/sh+1,000→ 3,457 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2022-03-01$197.58/sh−1,000→ 1,457 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2022-03-01$198.48/sh−1,000→ 2,457 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2022-03-01+1,000→ 0 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-04$288.00/sh−1,000→ 12,337 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$302.00/sh+1,285→ 13,337 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2021-11-02+1,285→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2021-11-02$128.18/sh+1,285→ 14,622 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-08-04$250.50/sh−780→ 971 total
Award
REPLIGEN CORP$RGEN
Common Stock
2021-05-13+457→ 1,751 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2021-05-13+1,151→ 1,151 total
Gift
REPLIGEN CORP$RGEN
Common Stock
2021-03-12−170→ 1,294 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2021-03-03$205.00/sh−1,000→ 1,464 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2021-03-03+1,000→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2021-03-03$26.12/sh+1,000→ 2,464 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2020-11-11$187.73/sh−934→ 1,464 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2020-11-11$38.76/sh+934→ 2,398 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2020-11-11+934→ 1,000 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2020-07-31$151.77/sh−986→ 1,464 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2020-07-31+2,109→ 0 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2020-07-31$151.96/sh−2,109→ 2,450 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2020-07-31$67.71/sh+2,109→ 4,559 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2020-05-13+1,285→ 1,285 total
Award
REPLIGEN CORP$RGEN
Common Stock
2020-05-13+527→ 2,450 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2020-03-16$91.48/sh−1,000→ 1,923 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2020-03-16$38.76/sh+500→ 2,423 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2020-03-16−500→ 1,934 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2020-03-16−500→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2020-03-16$42.07/sh+500→ 2,923 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2020-03-04$42.07/sh+2,804→ 6,719 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2020-03-04−2,804→ 500 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2020-03-04−1,992→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2020-03-04$41.19/sh+1,992→ 3,915 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2020-03-04$88.82/sh−4,796→ 1,923 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2020-03-03$85.72/sh−2,225→ 1,923 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2019-05-15+2,109→ 2,109 total
Award
REPLIGEN CORP$RGEN
Common Stock
2019-05-15+923→ 4,148 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2018-11-05$65.75/sh−1,763→ 3,225 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2018-08-22$51.44/sh−2,366→ 4,988 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2018-06-06$44.31/sh−1,932→ 7,354 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2018-05-16+3,304→ 3,304 total
Award
REPLIGEN CORP$RGEN
Common Stock
2018-05-16+1,486→ 9,286 total
Gift
REPLIGEN CORP$RGEN
Common Stock
2018-05-15−900→ 7,800 total
Sale
REPLIGEN CORP$RGEN
Common Stock
2018-03-08$36.16/sh−4,696→ 8,700 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2018-03-08$18.12/sh+3,696→ 13,396 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2018-03-08−3,696→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2018-03-08−1,000→ 0 total
Exercise/Conversion
REPLIGEN CORP$RGEN
Common Stock
2018-03-08$3.22/sh+1,000→ 9,700 total
Award
REPLIGEN CORP$RGEN
Common Stock
2017-05-18+1,206→ 8,700 total
Award
REPLIGEN CORP$RGEN
Stock Option (Right to Buy)
2017-05-18+2,434→ 2,434 total

Companies

REPLIGEN CORP
Director
$RGEN

Recent Filings

Address

C/O REPLIGEN CORPORATION 41 SEYON STREET, BUILDING 1, SUITE 100

WALTHAM, MA, 02453

View on SEC.gov